BIOSTAR OIA STREP B * GBS30

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 00,06 report with the FDA on 2008-03-12 for BIOSTAR OIA STREP B * GBS30 manufactured by Inverness Medical-biostar Inc.

Event Text Entries

[21699477] Lab reported mother was screened for group b strep using the biostar oia strep b assay during labor. Vaginal specimen was taken according to directions for use/package insert. Separate specimen was taken for culture. Oia rapid assay was negative; no prophylactic antibiotic was administered. Infant developed respiratory distress following birth, and died the following day. Autopsy indicated gbs sepsis.
Patient Sequence No: 1, Text Type: D, B5


[21823806] Initial assessment: device performed within specification (reference package insert). In clinical trials, oia negative 66% when 24hr direct culture also negative, oia positive 34% when only broth amplification positive. Clinical specimen most probably below limit of detection of assay. Device evaluation (returned & retained devices): unable to confirm complaint; retention devices perform within specification at limit of detection. Returned devices show significant damage to surfaces, including pre-assay surfaces, making low end interpretation difficult. However, positive signals were obtained with one colony from swab of agar culture and with low/moderate standards. Returned devices performed within release specifications, but it is noted that significant surface damage not present on retained kit made interpretation more difficult on returned devices. Surface damage was not reported as a part of the complaint, and the lab is proficient with oia assay. Follow-up with lab indicated controls performed as expected, no surface damage reported. Surface damage most likely occurred during return shipping and did not contribute to lab's negative result.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number1720655-2007-00001
MDR Report Key1012565
Report Source00,06
Date Received2008-03-12
Date of Report2008-03-12
Date of Event2007-04-01
Date Mfgr Received2007-04-04
Date Added to Maude2008-03-17
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location0
Manufacturer Street331 SOUTH 104TH STREET
Manufacturer CityLOUISVILLE CO 80027
Manufacturer CountryUS
Manufacturer Postal80027
Manufacturer Phone3035303888
Manufacturer G1*
Manufacturer Street*
Manufacturer City*
Manufacturer Country*
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameBIOSTAR OIA STREP B
Generic NameRAPID IMMUNOASSAY FOR GR. B STREP
Product CodeGTY
Date Received2008-03-12
Returned To Mfg2007-04-16
Model Number*
Catalog NumberGBS30
Lot Number176180
ID Number*
Device Expiration Date2007-07-31
OperatorHEALTH PROFESSIONAL
Device AvailabilityR
Device Eval'ed by MfgrY
Implant FlagN
Date Removed*
Device Sequence No1
Device Event Key980073
ManufacturerINVERNESS MEDICAL-BIOSTAR INC
Manufacturer Address* LOUISVILLE CO 80027 US


Patients

Patient NumberTreatmentOutcomeDate
101. Death 2008-03-12

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.